42 results on '"Gaebel, Ralf"'
Search Results
2. New Approaches in Heart Research: Prevention Instead of Cardiomyoplasty?
3. Intramyocardial fate and effect of iron nanoparticles co-injected with MACS® purified stem cell products
4. The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
5. Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration
6. The CD4+AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function
7. Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart
8. Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3
9. Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
10. Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans- Plantation Post MI
11. 18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction
12. CD271+ Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
13. Additional file 4: Figure S2. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
14. Additional file 7: Figure S6. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
15. Additional file 10: Figure S3. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
16. Additional file 5: Table S3. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
17. Additional file 3: Table S2. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
18. Additional file 6: Figure S5. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
19. Additional file 2: Table S1. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
20. Additional file 9: Figure S7. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
21. Additional file 8: Table S4. of GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
22. Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans-Plantation Post MI.
23. Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
24. Vimentin-Induced Cardiac Mesenchymal Stem Cells Proliferate in the Acute Ischemic Myocardium
25. Spray- and laser-assisted biomaterial processing for fast and efficient autologous cell-plus-matrix tissue engineering
26. Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
27. Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products
28. GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration
29. Cardiac Mesenchymal Stem Cells Proliferate Early in the Ischemic Heart
30. The CD4+ AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function
31. Exploiting AT2R to Improve CD117 Stem Cell Function In Vitro and In Vivo - Perspectives for Cardiac Stem Cell Therapy
32. Direct sprayed endothelialization, basement membrane and cell junction development on biological and artificial products are highly substrate-dependent and require optimized biofunctionalization
33. GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration.
34. Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium
35. Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration
36. Laser Printing of Skin Cells and Human Stem Cells
37. Is the intravascular administration of mesenchymal stem cells safe?
38. The CD4+ AT2R+ T cell subpopulation improves post-infarction remodelling and restores cardiac function.
39. The CD4+AT2R+T cell subpopulation improves post-infarction remodelling and restores cardiac function
40. Angiogenic Potential of Bone Marrow Derived CD133 + and CD271 + Intramyocardial Stem Cell Trans- Plantation Post MI.
41. CD271 + Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model.
42. GMP-conformant on-site manufacturing of a CD133 + stem cell product for cardiovascular regeneration.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.